
Thermo Fisher Scientific Calbindin 1 (CALB1) Monoclonal Antibody (CALB1/2364)
Calbindin 1(CALB1) 단백질을 인식하는 Mouse monoclonal antibody. ELISA 및 Peptide Array에 사용 가능하며, Human 시료에 반응. Protein A/G로 정제된 1 mg/mL 액상 제품으로, PBS(pH 7.4)에 보존제 없이 제공됨.
- 카탈로그번호
- 793-MSM1-P1ABX
- 판매단위
- pk
카탈로그
1개 옵션 · 카탈로그 번호를 클릭하면 복사됩니다Thermo Fisher Scientific · Thermo Fisher Scientific Calbindin 1 (CALB1) Monoclonal Antibody (CALB1/2364)
Applications and Tested Dilution
| Application | Tested Dilution |
|---|---|
| ELISA | Assay-dependent |
| Peptide Array | Assay-dependent |
Product Specifications
| 항목 | 내용 |
|---|---|
| Species Reactivity | Human |
| Host / Isotype | Mouse / IgG1, kappa |
| Class | Monoclonal |
| Type | Antibody |
| Clone | CALB1/2364 |
| Immunogen | Recombinant fragment (around aa 7-96) of human CALB1 protein |
| Conjugate | Unconjugated |
| Form | Liquid |
| Concentration | 1 mg/mL |
| Purification | Protein A/G |
| Storage Buffer | PBS, pH 7.4 |
| Contains | No preservative |
| Storage Conditions | -20°C, Avoid Freeze/Thaw Cycles |
| Shipping Conditions | Ambient (domestic); Wet ice (international) |
Target Information
Calbindin-D-28K (also termed vitamin D-dependent calcium-binding protein, or cholecalcin) is a highly conserved 28 kDa calcium-binding protein with broad tissue distribution. It belongs to a family of low molecular weight calcium-binding proteins (CaBPs), including calmodulin, S-100, parvalbumin, and troponin C. These proteins share homologous primary structures containing conserved EF-hand motifs responsible for Ca²⁺ binding.
Calbindin-D-28K is predominantly found in specific neuronal subpopulations of the central and peripheral nervous systems, as well as in epithelial cells involved in calcium transport, such as distal tubular cells and cortical collecting tubules of the kidney, and in enteric neuroendocrine cells.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Thermo Fisher Scientific 상품 둘러보기
전체보기문의
0개 · 배송·재고 문의는 실시간 상담이 빠릅니다아직 등록된 문의가 없어요.
